Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 plus paclitaxel in HER2-negative locally advanced or metastatic breast cancer
2011-005932-24Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing BKM120 + paclitaxel with Placebo + paclitaxel (2 arms). Primary endpoints: Progression-free survival in PI3K pathway activated subpopulation and Progression-free survival in full population. Started May 2012; status: completed.
02
Drugs
buparlisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-005932-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005932-24.